Innovative polatuzumab vedotin plus R-CHP therapy reshapes treatment of older adult patients with diffuse large B-cell lymphoma.

The genotoxic gut bacterium pks+ E coli is enriched in CRCs in people with Lynch syndrome, and its presence within the ...